New COVID-19 strategy: Vaccinate potential superspreaders first

by Macquarie UniversityCredit: Pixabay/CC0 Public DomainWith thousands of scientists around the world racing to develop a vaccine for COVID-19, policy makers may need to decide who is at the fron

Updated on: April 12,2024 11

New COVID-19 strategy: Vaccinate potential superspreaders first

by Macquarie UniversityCredit: Pixabay/CC0 Public DomainWith thousands of scientists around the world racing to develop a vaccine for COVID-19, policy makers may need to decide who is at the fron

Updated on:April 12,2024 11

Antibody production in patients hospitalized with COVID-19

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAntibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COV

Updated on: April 12,2024 20

Antibody production in patients hospitalized with COVID-19

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAntibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COV

Updated on:April 12,2024 20

How COVID-19 alters the immune system

by Ludwig Maximilian University of MunichDendritic cell. Credit: D. DudziakCOVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say LMU researcher

Updated on: April 12,2024 20

How COVID-19 alters the immune system

by Ludwig Maximilian University of MunichDendritic cell. Credit: D. DudziakCOVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say LMU researcher

Updated on:April 12,2024 20

COVID-19: Do not forget the host in treating this disease

by Jeff Hansen,University of Alabama at BirminghamRandy Cron, M.D., Ph.D. Credit: University of Alabama at BirminghamRandy Cron, M.D., Ph.D., is an expert in a dangerous immune reaction to some

Updated on: April 12,2024 20

COVID-19: Do not forget the host in treating this disease

by Jeff Hansen,University of Alabama at BirminghamRandy Cron, M.D., Ph.D. Credit: University of Alabama at BirminghamRandy Cron, M.D., Ph.D., is an expert in a dangerous immune reaction to some

Updated on:April 12,2024 20

COVID-19 vaccination: How the body builds immune memory in organs

by Charité - Universitätsmedizin BerlinCredit: CC0 Public DomainOne shot in the arm, and the whole body is protected. But how? For one thing, the immune system produces antibodies and cells that

Updated on: April 12,2024 18

COVID-19 vaccination: How the body builds immune memory in organs

by Charité - Universitätsmedizin BerlinCredit: CC0 Public DomainOne shot in the arm, and the whole body is protected. But how? For one thing, the immune system produces antibodies and cells that

Updated on:April 12,2024 18

Will COVID-19 vaccines need to be adapted regularly?

by Charité - Universitätsmedizin BerlinJust like thephylogenetic tree of the influenza virus subtype H3N2 (right), the phylogenetic tree of the ‘common cold’ coronavirus 229E (left) shows a

Updated on: April 12,2024 11

Will COVID-19 vaccines need to be adapted regularly?

by Charité - Universitätsmedizin BerlinJust like thephylogenetic tree of the influenza virus subtype H3N2 (right), the phylogenetic tree of the ‘common cold’ coronavirus 229E (left) shows a

Updated on:April 12,2024 11

COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant

by Washington University School of MedicineCredit: Pixabay/CC0 Public DomainPeople who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used

Updated on: April 12,2024 19

COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant

by Washington University School of MedicineCredit: Pixabay/CC0 Public DomainPeople who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used

Updated on:April 12,2024 19

How CD4+ T cells respond to SARS-CoV-2 in COVID-19 recovered patients

by Università della Svizzera italianaCredit: Università della Svizzera italianaAn international team of researchers from the Institute for Research in Biomedicine, affiliated to the Università della S

Updated on: April 10,2024 11

How CD4+ T cells respond to SARS-CoV-2 in COVID-19 recovered patients

by Università della Svizzera italianaCredit: Università della Svizzera italianaAn international team of researchers from the Institute for Research in Biomedicine, affiliated to the Università della S

Updated on:April 10,2024 11

Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases

by Stefan Zorn, Medizinische Hochschule HannoverLevel of Problems Experienced by Patients. Patients were able to provide levels on a scale from 0 to 5 (0 = no problems, 5 = unable/extreme problems) fo

Updated on: April 10,2024 17

Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases

by Stefan Zorn, Medizinische Hochschule HannoverLevel of Problems Experienced by Patients. Patients were able to provide levels on a scale from 0 to 5 (0 = no problems, 5 = unable/extreme problems) fo

Updated on:April 10,2024 17

Simple test for COVID-19 could prioritize treatments for individuals most at risk

by Flinders UniversitySROC curve with 95% confidence region and prediction region for the SII towards prediction of severe disease or mortality. Credit:Frontiers in Immunology(2023).

Updated on: April 10,2024 17

Simple test for COVID-19 could prioritize treatments for individuals most at risk

by Flinders UniversitySROC curve with 95% confidence region and prediction region for the SII towards prediction of severe disease or mortality. Credit:Frontiers in Immunology(2023).

Updated on:April 10,2024 17

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th

Updated on: April 10,2024 14

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th

Updated on:April 10,2024 14

COVID-19 antibody testing needn't be perfect to guide public health and policy decisions

by University of Utah Health SciencesCredit: CC0 Public DomainWhile it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available t

Updated on: April 10,2024 12

COVID-19 antibody testing needn't be perfect to guide public health and policy decisions

by University of Utah Health SciencesCredit: CC0 Public DomainWhile it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available t

Updated on:April 10,2024 12